Drug: lamivudine Quarter: 2016Q3
Total Drug/Injury Combinations: 443 Number of Pages: 23
DRUGNAME | PT | EventCount | |
---|---|---|---|
LAMIVUDINE. | Foetal exposure during pregnancy | 82 | view events |
LAMIVUDINE. | Drug resistance | 65 | view events |
LAMIVUDINE. | Exposure during pregnancy | 53 | view events |
LAMIVUDINE. | Hepatitis B | 46 | view events |
LAMIVUDINE. | Virologic failure | 31 | view events |
LAMIVUDINE. | Treatment noncompliance | 29 | view events |
LAMIVUDINE. | Exposure during breast feeding | 24 | view events |
LAMIVUDINE. | Anaemia | 23 | view events |
LAMIVUDINE. | Treatment failure | 20 | view events |
LAMIVUDINE. | Viral mutation identified | 20 | view events |
LAMIVUDINE. | Hepatitis B DNA increased | 16 | view events |
LAMIVUDINE. | Pathogen resistance | 15 | view events |
LAMIVUDINE. | Rash | 15 | view events |
LAMIVUDINE. | Diarrhoea | 14 | view events |
LAMIVUDINE. | Hyperlipidaemia | 14 | view events |
Lamivudine and Zidovudine Tablets | Exposure during pregnancy | 12 | view events |
LAMIVUDINE. | Maternal exposure during pregnancy | 12 | view events |
LAMIVUDINE. | Autoimmune hepatitis | 11 | view events |
LAMIVUDINE. | Caesarean section | 11 | view events |
LAMIVUDINE. | Mycobacterium avium complex infection | 11 | view events |
Total Drug/Injury Combinations: 443 Number of Pages: 23
NOTE: EventCount numbers on this page include duplicate entries from event reports. (e.g. One event has DrugX entered twice, which equals 2 on this page.) The "view events" page treats these duplicates as single entries. (e.g. The 2 entries of DrugX for a single event are counted as 1 instance.)